Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ulrike Hanauske"'
Autor:
Ulrike Hanauske, Hans-J. Meyer, Sigfried Sandner, Johann Rastetter, Hans-R. Raab, Mathias Freund, D. Neukam, S. Danhauser-Riedl, Axel-R. Hanauske, H. Poliwoda, Werner de Riese, Enno Bauer
Publikováno v:
European journal of cancer (Oxford, England : 1990). (10)
The availability of human recombinant erythropoietin (rhE) has provided new therapeutic opportunities for a variety of anemic states [1]. Besides treatment of renal anemia, anemia of malignancy is a potential target for the clinical use of rhE [2–4
Publikováno v:
Current Problems in Cancer. 9:1-50
Publikováno v:
European Journal of Cancer and Clinical Oncology. 23:603-605
IMPORTANT goals in the treatment of patients with malignant diseases are to minimize the side effects of chemotherapy and to optimize the chance for prolonged survival. Several attempts have been made over the past decades to develop in vitro assays
Publikováno v:
International journal of cell cloning. 6(3)
Transforming growth factor-alpha (TGF alpha) is a low molecular weight peptide that has been implicated in an autocrine growth-stimulation of tumor cell lines in vitro. Although its mRNA has been detected in biopsies from human malignancies, the impo
Autor:
Martha H. Marshall, Axel-R. Hanauske, Daniel D. Von Hoff, Victoria A. Muggia, Ulrike Hanauske
Publikováno v:
International journal of cell cloning. 5(2)
Vanadium is a trace element widely distributed in nature. It interferes with a variety of enzyme systems and is also reported to increase DNA-synthesis and in vitro clonal growth of human and mouse fibroblasts. The purpose of the present study was to
A new in vitro screening system for anticancer drugs for the treatment of non-small cell lung cancer
Publikováno v:
Selective cancer therapeutics. 5(3)
We have evaluated a semiautomated radiometric assay (BACTEC 460 system) for screening of activity of anticancer drugs against human non-small cell lung cancer cell lines. Cells from seven cell lines were exposed to standard antineoplastic agents at f